Bailard, Inc. Viatris Inc Transaction History

Bailard, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$11.27 - $13.53 $2,366 - $2,841	210 Added 1.37%	15,530 $185,000
Q4 2023 Feb 02, 2024	SELL	$8.77 - $10.85 $3,578 - $4,426	-408 Reduced 2.59%	15,320 $165,000
Q3 2023 Oct 24, 2023	SELL	$9.59 - $11.35 $1,208 - $1,430	-126 Reduced 0.79%	15,728 $155,000
Q2 2023 Jul 20, 2023	SELL	$9.02 - $10.29 $6,097 - $6,956	-676 Reduced 4.09%	15,854 $158,000
Q1 2023 May 08, 2023	BUY	$9.2 - $12.26 $1,251 - $1,667	136 Added 0.83%	16,530 $159,000
Q4 2022 Feb 02, 2023	SELL	$8.72 - $11.56 $540 - $716	-62 Reduced 0.38%	16,394 $182,000
Q2 2022 Jul 27, 2022	SELL	$9.95 - $12.27 $1,343 - $1,656	-135 Reduced 0.81%	16,456 $172,000
Q1 2022 Apr 25, 2022	SELL	$9.81 - $15.4 $2,864 - $4,496	-292 Reduced 1.73%	16,591 $181,000
Q4 2021 Feb 10, 2022	SELL	$12.09 - $14.68 $1,027 - $1,247	-85 Reduced 0.5%	16,883 $228,000
Q3 2021 Nov 15, 2021	SELL	$13.25 - $15.13 $35,708 - $40,775	-2,695 Reduced 13.71%	16,968 $230,000
Q2 2021 Aug 13, 2021	SELL	$12.97 - $16.15 $2,905 - $3,617	-224 Reduced 1.13%	19,663 $281,000
Q1 2021 May 13, 2021	BUY	$13.59 - $18.54 $270,264 - $368,704	19,887 New	19,887 $278,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.